|
« FDA: Actos Must Warn of Bladder Cancer Risk |
Main
| Actoplus Met Bladder Cancer Risk »
|
 |
|
Duetact Bladder Cancer Side Effect
|
The FDA has warned that long-term use of the diabetes drug Duetact comes with an increased risk of bladder cancer. Although most of the coverage in the news and on the internet has focused on Actos, Duetact has the same bladder cancer side effect potential, and was included in the FDA's warning.
Duetact is the brand name for Actos (pioglitazone) when combined with another diabetes drug called glimepiride. Duetact was approved for sale in the United States in 2006. Like
Actos, Duetact is manufactured by a Japanese company called Takeda Pharmaceuticals. Also like
Actos, studies have shown that long-term use of Duetact increases the risk of developing bladder cancer.
If you or a loved one developed bladder cancer after using Duetact for more than one year, there is a possibility that Duetact was the cause. Because Duetact contained no warning that using it might cause bladder cancer, Takeda Pharmaceuticals may be legally liable for the injury.
Learn more about the risks of Duetact and Actos HERE.
|
|
|
|
|
|
|
Posted By DeCarli Law on
August 18, 2011 02:12 pm |
Permalink
|
|